Last refreshed Jun 5, 2026 | 24 journals analyzed | 712 papers indexed

Best journals to publish nanoparticle based drug delivery research

Nanoparticle-based drug delivery is a rapidly evolving field in biomedical research, focusing on the use of nanoscale carriers to improve the therapeutic efficacy and safety of drugs. This approach addresses challenges such as poor solubility, non-specific distribution, and rapid clearance of conventional therapeutics. By engineering nanoparticles with tailored properties—size, surface charge, and targeting ligands—researchers aim to enhance drug accumulation at disease sites while minimizing systemic toxicity. The field encompasses diverse materials, including liposomes, polymeric nanoparticles, dendrimers, and inorganic carriers, each offering unique advantages for controlled release and targeted delivery. Applications span cancer therapy, infectious diseases, and regenerative medicine. The analysis of 24 journals and 712 indexed papers provides a comprehensive overview of current research trends, publication venues, and impact metrics, aiding researchers in identifying suitable outlets for their work.

Submission shortlist
10
ranked journals with impact-factor matches

Top journals for this topic

Ranked by topic paper volume first, then matched impact factor.

#1
Pharmaceutics
ISSN: 1999-4923Source: Pharmaceutics
IF5.5
QuartileQ1
Topic papers30
OAUnknown
APCUnknown
#6
Nanoscale
ISSN: 2040-3364Source: Nanoscale
IF5.1
QuartileQ1
Topic papers15
OANo
APCUnknown
#7
ACS nano
ISSN: 1936-0851Source: ACS Nano
IF16.0
QuartileQ1
Topic papers13
OANo
APCUnknown

Match my manuscript to these journals

Use the recommendation workflow with this topic prefilled, then compare scope, quartile, impact factor, and likely fit before submission.

Match my manuscript

Recent representative papers

Photodynamic gel-bombs enhance tumor penetration and downstream synergistic therapies.

Signal transduction and targeted therapy | IF 52.7 | Q1 | 2025 Mar 19

PubMed

Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities.

Science (New York, N.Y.) | IF 45.8 | Q1 | 2012 Nov 16

PubMed

Principles of nanoparticle design for overcoming biological barriers to drug delivery.

Nature biotechnology | IF 41.7 | Q1 | 2015 Sep

PubMed

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma.

Journal of hematology & oncology | IF 40.4 | Q1 | 2020 Nov 02

PubMed

Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems.

Chemical Society reviews | IF 39.0 | Q1 | 2017 Oct 02

PubMed

Top contributing institutions

High-confidence ROR-mapped institutions from this cached PubMed topic.

Institution research map
Map points come from primary affiliations in the latest 100 papers; broader PubMed distribution uses the latest 712 records.
63
mapped
23
countries
100
map parsed
27
pending
9%
cache
Institution density
Primary affiliation map
latest 100 papers
Signal densitylow to high
localregionalstrongleader
Selected institution

Galgotias University

Greater Noida, India
Papers
2
Mentions
2
Avg IF
n/a
Confidence
100%
Signal leaders
View ROR record

Related topic journal pages

moyamoya disease
0 shared journals | 1 shared institutions

Need the research overview?

This page is for submission decisions. The sibling PubMed overview focuses on research trends, maps, and article-level metrics.

See research overview